MarginsXMarginsX
Home › Markets › BTCY

Biotricity Inc. (BTCY)

BTCY is quoted over the counter, not listed on an exchange. Biotricity Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close · November 16, 2026
$0.0521
-13.2% on the day
1-year return
-90.9%
Market cap
$1.0M
Nano cap. From the Nov 16, 2026 close × 19.9M shares (10-Q cover page, Aug 19, 2026)
P/E and P/S
Net loss over the period · 0.1×
On trailing twelve months to June 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-16.

Profile

FieldValue
TickerBTCY, quoted over the counter
SEC CIK0001630113
OTC Markets tierOTCQB (price source, 2026-11-13)
SEC industry codeSurgical & Medical Instruments & Apparatus
Business addressRedwood City, CA
Incorporated inNV

Warning signs

Cash runway
Cash-flow positive
$467K cash at June 30, 2026
Share count, 1 year
-25.0%
2025-08-13 to 2026-08-19 · +139.3% over 3 years
Going-concern doubt
Yes
10-Q filed August 19, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"Those conditions raise substantial doubt about its ability to continue as a going concern for a period of one year from the issuance of these condensed consolidated interim financial statements."
10-Q 2026-08-19
Cash and burn$467K cash; operating cash flow $40K a quarter.Report 2026-06-30
Shares outstanding19,914,003 (2026-08-19); 26,567,769 a year earlier; 8,321,342 three years earlier.Cover page 2026-08-19
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorSRCO Professional Corporation, Richmond Hill, CanadaPCAOB Form AP 2026-07-27
Late filings, 12 months2 NT noticesNT 10-Q 2026-08-17
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q1 2027
2026-06-30
$4.3M-$959K$507K$467K$14.9M$16.4M10-Q 2026-08-19
Q4 2026
2026-03-31
$4.3M-$324K-$21K$150K$15.0M$16.0M10-K 2026-07-14
Q3 2026
2025-12-31
$4.0M-$717K-$740K$256K$13.7M$15.5M10-Q 2026-02-11
Q2 2026
2025-09-30
$3.9M-$691K$416K$308K$13.0M$15.1M10-Q 2025-11-14
Q1 2026
2025-06-30
$3.9M-$672K-$373K$391K$10.1M$14.5M10-Q 2026-08-19
Q4 2025
2025-03-31
$3.7M-$1.9M-$401K$365K$16.0M$13.8M10-K 2026-07-14
Q3 2025
2024-12-31
$3.6M-$1.2M-$88K$510K$11.8M$13.3M10-Q 2026-02-11
Q2 2025
2024-09-30
$3.3M-$1.6M-$397K$173K$11.5M$12.6M10-Q 2025-11-14

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-12025-12-19
Latest annual report10-K2026-07-14
Latest quarterly / interim10-Q2026-11-16
Latest current report8-K2026-09-28
Latest proxyDEF 14A2024-08-05

Source: SEC EDGAR submissions feed, 319 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier